Nel et al., found a higher frequency of functional variants in the HLA-DRB1 region in a selected sample of African juveniles with treatment-resistant ophthalmoplegia (see below) compared to MG cases who responded to therapy (65), as well as the closely linked HLA-DPB1 region (2). This evidence concerns the gene HLA-DPB1 and myasthenia gravis.